This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It says the price increases were imposed “as though a new version of Acthar came on the market in 2013, when in fact, it did not,” which allowed it to ignore all price increases prior to 2013 in its rebate calculations.
43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for PharmaceuticalManufacturing. Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceuticalmanufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. per cent of global patents to almost 2 per cent.
AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.
Microbes developing resistance to disinfectants is a major emerging problem in pharmaceuticalmanufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health. Microbial resistance is one of the factors responsible for such failings.
When I finally sought treatment in 2013, I learned how to turn my ADHD into a strength by better managing it. “Whether competing in the NFL, or in life, many of us feel that we can’t show weakness,” says Thomas. Unfortunately, this way of thinking has kept millions of adults and children from getting the treatment they need.
Implementing PAT in (bio)pharmaceuticalmanufacturing New sensors or larger equipment with more complex setups (software and hardware) require stringent procedures to become fully implemented in a good manufacturing practice (GMP) manufacturing facility. GMP Audits in Pharmaceutical and Biotechnology Industries.
Paradigm Shift in Drug Development: Analytical Quality by Design and Analytical Procedure Life Cycle In today’s pharmaceuticalmanufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products.
Pharmaceuticalmanufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.
First of all - the text of the law passed by Congress and signed into law on 11/27/2013 is available here, on page 562-595. Unfortunately, no one, from the manufacturers to the wholesalers to the dispensers to the FDA themselves has actually complied with the will of the 2013 Congress as written in the text of the DSCSA.
On July 1, drugmakers raised the wholesale price on more than 123 drugs in what’s the largest number of mid-year price hikes since 2013, according to data from drug pricing nonprofit 46brooklyn and the Elsevier Gold Standard Drug Database. Continue to STAT+ to read the full story…
The lawsuits involving pharmaceuticalmanufacturers focus mainly on the “first wave” of the opioid crisis in the 1990s and 2000s, which the CDC says was driven by increased prescribing of painkillers.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content